Curated News
By: NewsRamp Editorial Staff
August 07, 2026

Earth Science Tech Reports 57% Net Income Surge in Q1 2027

TLDR

  • Earth Science Tech (ETST) boosts net income 57% to $715,697, repurchases 3.7M shares, and eyes uplisting for better liquidity.
  • ETST's Q1 2027 shows revenue up 3% to $9M, gross profit $6.3M, operating cash flow doubled to $707,131, and no debt from buyback.
  • ETST expands telehealth and pharmacy fulfillment, aiming to improve patient care integration across the US, making healthcare more accessible.
  • ETST's annual meeting on Aug 31, 2026, includes voting on canceling Series B Preferred Stock and potential exchange uplisting.

Impact - Why it Matters

Earth Science Tech's strong financial performance demonstrates the viability of its integrated healthcare model. The company's strategic expansion in compounding pharmacy licensing and potential uplisting could enhance liquidity and investor confidence. For investors, this news signals growth and stability in a diversified health and wellness company, potentially impacting portfolio returns.

Summary

Earth Science Tech, Inc. (OTC: ETST), a diversified holding company focused on health and wellness, announced robust fiscal first-quarter 2027 results. The company reported a 57% year-over-year increase in net income to $715,697, with revenue of $9.0 million, up 3% from the prior-year period. Gross profit rose to $6.3 million, and operating cash flow more than doubled to $707,131. Total assets increased to $10.4 million, and diluted earnings per share improved to $0.003 from $0.001. During the quarter, the company repurchased and retired over 3.7 million common shares without adding debt.

All key operating subsidiaries remained profitable, and the company is expanding the licensing footprint of its compounding pharmacy operations across the United States. Management is also evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms. Investors will hear more at the annual shareholder meeting on Aug. 31, 2026, where they will vote on proposals including the cancellation of the Series B Preferred Stock and receive updates on a potential exchange uplisting aimed at improving liquidity and market visibility.

The company's vertically integrated healthcare platform combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment, supported by investments in real estate and asset management. The news was disseminated by InvestorWire, a specialized communications platform within the Dynamic Brand Portfolio @ IBN, which provides wire-grade press release syndication and editorial distribution to 5,000+ outlets.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Earth Science Tech Reports 57% Net Income Surge in Q1 2027

blockchain registration record for this content.